Page 16 from the Webinar is a bit concerning IMO with this comment (see below ADC extract) "Implementation of required preclinical studies to demonstrate proof-of-concept" ... what has Merck been doing for the last 3 years ??? Weren't they undertaking these preclinical studies with ADCs ? Are we starting all over again ....doesn't say much for our supposed partner Merck ?
Perhaps that's why Merck went with Daiichi Sankyo and committed up to $22 billion for their ADCs .... they obviously weren't that impressed or they would have signed a deal with us surely after all this research (3 Years) ?
https://www.fiercepharma.com/pharma/merck-bags-chance-test-adcs-based-starpharma-delivery-tech#:~:text=Merck has tightened its ties,a dendrimer drug delivery platform.
Merck bags chance to test ADCs based on Starpharma delivery tech
Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable it to evaluate candidates based on a dendrimer drug delivery platform.
Last year, Merck struck a deal to perform a preclinical evaluation of dendrimer-based ADCs made using Starpharma’s DEP delivery technology. The deal cleared Merck to take a close look at the fruits of a drug delivery platform that is designed to yield ADCs with greater homogeneity, site specific attachment and higher drug-antibody ratios than conventional candidates.
Page 16 Webinar Extract
- Forums
- ASX - By Stock
- SPL
- Annual Report 2024
Annual Report 2024, page-7
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.5¢ |
Change
0.008(9.20%) |
Mkt cap ! $39.14M |
Open | High | Low | Value | Volume |
9.0¢ | 9.5¢ | 8.8¢ | $334.2K | 3.710M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 50354 | 9.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 22908 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 760087 | 0.089 |
2 | 147200 | 0.087 |
3 | 118061 | 0.086 |
3 | 220000 | 0.085 |
1 | 100000 | 0.084 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 22908 | 2 |
0.096 | 5000 | 1 |
0.099 | 6837 | 1 |
0.100 | 71848 | 3 |
0.105 | 370000 | 2 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online